KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other Working Capital Changes (2016 - 2025)

Neogenomics' Other Working Capital Changes history spans 16 years, with the latest figure at -$573000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 108.65% year-over-year to -$573000.0; the TTM value through Dec 2025 reached -$1.6 million, down 122.76%, while the annual FY2025 figure was -$1.6 million, 122.76% down from the prior year.
  • Other Working Capital Changes reached -$573000.0 in Q4 2025 per NEO's latest filing, up from -$642000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $6.6 million in Q4 2024 to a low of -$3.5 million in Q3 2021.
  • Average Other Working Capital Changes over 5 years is $576100.0, with a median of $55500.0 recorded in 2021.
  • The largest YoY upside for Other Working Capital Changes was 4570.59% in 2021 against a maximum downside of 3302.78% in 2021.
  • A 5-year view of Other Working Capital Changes shows it stood at $684000.0 in 2021, then plummeted by 457.46% to -$2.4 million in 2022, then grew by 18.81% to -$2.0 million in 2023, then skyrocketed by 433.85% to $6.6 million in 2024, then plummeted by 108.65% to -$573000.0 in 2025.
  • Per Business Quant, the three most recent readings for NEO's Other Working Capital Changes are -$573000.0 (Q4 2025), -$642000.0 (Q3 2025), and -$3.4 million (Q2 2025).